This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gasowski, J. Articles by MacGregor, G. A. Search for Related Content PubMed Articles by Gasowski, J. Articles by MacGregor, G. A. Related Collections Other diagnostic testing

(Hypertension. 2005;45:e16.)
© 2005 American Heart Association, Inc.

Hypertension Electronic Pages

Ouabain and Serum Sodium

Jerzy Gsowski

Study Coordinating Centre, Laboratory of Hypertension Department of Molecular and Cardiovascular Research, University of Leuven, Belgium and, Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, Cracow, Poland

Paolo Manunta; Giuseppe Bianchi

The Division of Nephrology, Dialysis and Hypertension, University Vita Salute San Raffaele, Milan, Italy

Jan A. Staessen

Study Coordinating Centre, Laboratory of Hypertension Department of Molecular and Cardiovascular Research, University of Leuven, Belgium

An extract of the first 250 words of the full text is provided, because this article has no abstract.

To the Editor:

Sodium-dependent mechanisms play a role in the pathogenesis of hypertension. He et al recently demonstrated that in normotensive and hypertensive subjects an acute reduction in salt intake, from 350 to 10 mmol/d for 5 days, was associated with a decline in serum sodium by 3 mmol/L.¹ Conversely, a progressive increase in salt intake from 10 to 250 mmol/d by a daily amount of 50 mmol caused an increase in serum sodium in normotensive subjects, but not hypertensive patients.¹ These investigators speculated that small changes in serum sodium might directly affect the hypothalamic control of blood pressure through the local pituitary renin-angiotensin system.¹

Ouabain is a steroid hormone, which is released from the hypothalamus and the adrenal gland. It is implicated in sodium homeostasis and exerts direct actions on the vasculature, the heart,² and tubular sodium reabsorption.³ In individuals randomly recruited from a Flemish population, blood pressure increased by 2.2 mm Hg systolic and 1.4 mm Hg diastolic for each 50-mmol/d increment in urinary sodium excretion when the plasma ouabain concentration was below the median (140 pmol/L).⁴ No association between blood pressure and urinary sodium was found when plasma ouabain exceeded the median.⁴

In the same population,⁴ we tried to reproduce He’s observations in 369 subjects not using treatment with diuretics. Blood pressure was the average of 5 consecutive readings obtained at each of 2 home visits 4 to 6 weeks apart. The study sample included 48.0% men, 30.9% current smokers, and 25.5% hypertensive patients. Mean age was . . . [Full Text of this Article]

Feng J. He; Graham A. MacGregor

Blood Pressure Unit, St. George’s Hospital Medical School, London, United Kingdom

This article has been cited by other articles:

				R. A. Khalil Dietary salt and hypertension: new molecular targets add more spice Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R509 - R513. [Full Text] [PDF]

				J. E. Hall Hypertension Online Only: June 2005 Hypertension, June 1, 2005; 45(6): 1214 - 1214. [Full Text] [PDF]